Conversion Labs Expects Q3 2020 Record Revenue of $11.2 Million, up 254%; Subscription ARR Hits $19.3 million, up 458%
12 oct. 2020 07h35 HE
|
Conversion Labs, Inc.
NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its third quarter...
Conversion Labs Reports Preliminary Q2 2020 Revenues Climbing 241% to Record $9.2 Million; Raises 2020 Outlook to $40 Million+
07 juil. 2020 08h45 HE
|
Conversion Labs, Inc.
NEW YORK, July 07, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its second quarter...
Conversion Labs Reports Preliminary First Quarter 2020 Revenue Up 60% to Record $4.3 Million
21 avr. 2020 08h31 HE
|
Conversion Labs, Inc.
NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited revenue of approximately $4.3...
Conversion Labs Reports Preliminary 2019 Net Sales up 47% to Record $12.2 Million
15 janv. 2020 10h44 HE
|
Conversion Labs, Inc.
NEW YORK, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited net sales for the fourth...